Crush The Market

undefined Logo

Rigel Pharmaceuticals, Inc.

0.70 USD

-1.57%

Add To Watchlist

Page 1 of 23

2021-1999

Currency in USD2021
PeriodFY
Revenue149.24 Million
Cost Of Revenue1.08 Million
Gross Profit148.15 Million
Gross Profit Ratio0.99
Research And Development Expenses65.24 Million
General And Administrative Expenses0.00
Selling And Marketing Expenses0.00
Selling General And Administrative Expenses91.89 Million
Other Expenses0.00
Operating Expenses157.13 Million
Cost And Expenses158.21 Million
Interest Income47.00 Thousand
Interest Expense4.86 Million
Depreciation And Amortization1.16 Million
Ebitda-11.29 Million
Ebitdaratio-0.08
Operating Income-12.5 Million
Operating Income Ratio-0.08
Total Other Income Expenses Net-4.81 Million
Income Before Tax-17.31 Million
Income Before Tax Ratio-0.12
Income Tax Expense605.00 Thousand
Net Income-17.91 Million
Net Income Ratio-0.12
Eps-0.11
Epsdiluted-0.11
Weighted Average Shs Out168.75 Million
Weighted Average Shs Out Dil168.75 Million
Linkhttps://www.sec.gov/Archives/edgar/data/1034842/000155837022002551/0001558370-22-002551-index.htm
Final Linkhttps://www.sec.gov/Archives/edgar/data/1034842/000155837022002551/rigl-20211231x10k.htm

Crush The Market

We Use Cookies